Arbor Rapha Capital Bioholdings Corp. I (NASDAQ:ARCK – Get Rating) was the target of a significant increase in short interest during the month of December. As of December 30th, there was short interest totalling 10,300 shares, an increase of 1,371.4% from the December 15th total of 700 shares. Approximately 0.1% of the company's shares are short sold. Based on an average daily trading volume, of 54,500 shares, the short-interest ratio is currently 0.2 days.
Arbor Rapha Capital Bioholdings Corp. I Price Performance
Shares of ARCK stock opened at $11.90 on Wednesday. Arbor Rapha Capital Bioholdings Corp. I has a one year low of $9.93 and a one year high of $15.59. The company has a 50 day moving average price of $10.93 and a 200 day moving average price of $10.41.
Get
Arbor Rapha Capital Bioholdings Corp. I alerts:
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the company. Elequin Capital LP acquired a new stake in shares of Arbor Rapha Capital Bioholdings Corp. I in the 3rd quarter worth about $25,000. Mint Tower Capital Management B.V. bought a new position in shares of Arbor Rapha Capital Bioholdings Corp. I during the 3rd quarter valued at about $818,000. Parallax Volatility Advisers L.P. acquired a new position in shares of Arbor Rapha Capital Bioholdings Corp. I in the third quarter worth about $877,000. Balyasny Asset Management LLC boosted its holdings in shares of Arbor Rapha Capital Bioholdings Corp. I by 12.5% in the third quarter. Balyasny Asset Management LLC now owns 225,005 shares of the company's stock worth $2,277,000 after buying an additional 25,005 shares during the period. Finally, Saba Capital Management L.P. boosted its holdings in shares of Arbor Rapha Capital Bioholdings Corp. I by 18.1% in the third quarter. Saba Capital Management L.P. now owns 1,631,601 shares of the company's stock worth $16,512,000 after buying an additional 250,000 shares during the period. 68.70% of the stock is currently owned by hedge funds and other institutional investors.
About Arbor Rapha Capital Bioholdings Corp. I
(Get Rating)
Arbor Rapha Capital Bioholdings Corp. I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar Business Combination with one or more businesses. It intends to identify acquisition opportunities in the biopharmaceutical sector.
See Also
- Get a free copy of the StockNews.com research report on Arbor Rapha Capital Bioholdings Corp. I (ARCK)
- Insulet Has Potential To Gain More Than Analysts Are Forecasting
- Cathie Wood Is Buying These Stocks, Should You?
- Thor Industries Hammered Its Numbers. Is it a Buy?
- Tritium Is the Largest DC EV Charger Maker You've Never Heard Of
- United Airlines Soars Ahead of Earnings...Time to Deplane?
Receive News & Ratings for Arbor Rapha Capital Bioholdings Corp. I Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arbor Rapha Capital Bioholdings Corp. I and related companies with MarketBeat.com's FREE daily email newsletter.
Arbor Rapha Capital BioHoldings Corp.I(纳斯达克:ARCK-GET评级)是12月份空头股数大幅上涨的目标。截至12月30日,空头股数共有10300股,比12月15日的700股增加了1371.4%。该公司约0.1%的股票被卖空。以日均成交量五万四千五百股计算,目前短息比率为零点二天。
Arbor Rapha Capital BioHoldings Corp.I价格表现
Arck的股票周三开盘报11.90美元。Arbor Rapha Capital BioHoldings Corp.I的一年低点为9.93美元,一年高位为15.59美元。该公司的50日移动均线价格为10.93美元,200日移动均线价格为10.41美元。
到达
Arbor Rapha Capital BioHolding Corp.警报:
机构资金流入和流出
几家机构投资者和对冲基金最近对他们在该公司的头寸进行了调整。Elequin Capital LP在第三季度收购了Arbor Rapha Capital BioHoldings Corp.I价值约25,000美元的新股。铸币塔资本管理公司(Mint Tower Capital Management B.V.)在第三季度购买了Arbor Rapha Capital BioHoldings Corp.I的新头寸,价值约818,000美元。Parallax Volatility Advisers L.P.在第三季度收购了Arbor Rapha Capital BioHoldings Corp.I价值约87.7万美元的新股票头寸。Balyasny Asset Management LLC在第三季度增持了Arbor Rapha Capital BioHoldings Corp.I的股票12.5%。Balyasny Asset Management LLC现在拥有225,005股该公司的股票,价值2,277,000美元,在此期间又购买了25,005股。最后,Saba Capital Management L.P.在第三季度将其持有的Arbor Rapha Capital BioHoldings Corp.I的股票增加了18.1%。Saba Capital Management L.P.在此期间又购买了250,000股,现在拥有1,631,601股该公司股票,价值16,512,000美元。68.70%的股票目前由对冲基金和其他机构投资者持有。
关于Arbor Rapha Capital BioHoldings Corp.
(获取评级)
Arbor Rapha Capital BioHoldings Corp.I没有重大业务。公司专注于与一家或多家企业进行合并、资本换股、资产收购、股票购买、重组或类似的业务合并。它打算确定生物制药行业的收购机会。
另请参阅
- 免费获取StockNews.com关于Arbor Rapha Capital BioHoldings Corp.I(Arck)的研究报告
- Insulet有潜力获得超过分析师预测的收益
- 凯西·伍德正在购买这些股票,你应该这样做吗?
- 雷神工业重创了它的业绩。这是买来的吗?
- 氚是你从未听说过的最大的DC电动汽车充电器制造商
- 美国联合航空公司盈利前飙升...是时候下机了?
获得Arbor Rapha Capital BioHoldings Corp.I Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Arbor Rapha Capital BioHoldings Corp.I和相关公司的最新新闻和分析师评级的每日简要摘要。